Compare $DCOY vs $HCWB | Chartloom

Compare

$DCOY vs $HCWB

Decoy Therapeutics Inc · HCW Biologics Inc

DCOY

Decoy Therapeutics Inc

HCWB

HCW Biologics Inc

Compare $DCOY vs $HCWB

Comparing Decoy Therapeutics Inc and HCW Biologics Inc

DCOYDecoy Therapeutics Inc

HCWBHCW Biologics Inc

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

HCWBHCW Biologics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

707.0%

YTD performance

-76.2%

52W performance

-94.5%

FCF yield

-474.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DCOY

HCWB

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

HCWB

HCW Biologics Inc

Market Cap

DCOY$779K

HCWB$3M

Enterprise Value

DCOY$-8M

HCWB$8M

Price

DCOY$1.47

HCWB$1.60

P/E Ratio

DCOYN/A

HCWBN/A

P/S Ratio

DCOY3.42x

HCWB0.38x

EV/Sales

DCOY-33.00x

HCWB1.25x

EV/EBITDA

DCOY0.00x

HCWB0.00x

P/B Ratio

DCOY0.75x

HCWB0.51x

P/FCF Ratio

DCOYN/A

HCWBN/A

EV/FCF

DCOY0.90x

HCWB-0.69x

PEG Ratio

DCOYN/A

HCWBN/A

Forward P/E (NTM)

DCOYN/A

HCWBN/A

Forward P/S (NTM)

DCOYN/A

HCWBN/A

Revenue (TTM)

DCOY$228K

HCWB$7M

Revenue Growth (YoY)

DCOYN/A

HCWB707.0%

Forward Rev Growth

DCOY0.0%

HCWB5564.5%

Gross Margin (TTM)

DCOY48.6%

HCWB95.9%

Operating Margin (TTM)

DCOY0.0%

HCWB23.1%

EBITDA Margin (TTM)

DCOY-2668.9%

HCWB-82.2%

Net Margin (TTM)

DCOY-6348.7%

HCWB-318.5%

FCF Margin (TTM)

DCOY-3676.1%

HCWB-180.6%

Net Income (TTM)

DCOY$-14M

HCWB$-21M

FCF (TTM)

DCOY$-8M

HCWB$-12M

EPS (TTM)

DCOY-$27.16

HCWB-$16.12

ROE (TTM)

DCOY-31523.0%

HCWB-1932.0%

ROA (TTM)

DCOY-16715.0%

HCWB-2145.0%

ROIC (TTM)

DCOY-31523.0%

HCWB-859.0%

Cash

DCOY$8M

HCWB$741K

Debt

DCOY$0

HCWB$7M

Net Cash/Debt

DCOY$8M

HCWB$-6M

Current Ratio (TTM)

DCOY1.83x

HCWB0.06x

Quick Ratio (TTM)

DCOY1.77x

HCWB0.05x

Debt/Equity (TTM)

DCOY0.00x

HCWB0.88x

Debt/Assets (TTM)

DCOY0.0%

HCWB0.0%

Interest Coverage (TTM)

DCOYN/A

HCWBN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

HCWB0.00x

Beta

DCOY0.68

HCWB2.28

52W Performance

DCOY-97.0%

HCWB-94.5%

YTD Performance

DCOY-81.2%

HCWB-76.2%

% from 52W High

DCOY-97.4%

HCWB-94.3%

% from 52W Low

DCOY0.7%

HCWB6.7%

Asset Turnover (TTM)

DCOY0.03x

HCWB0.26x

FCF Yield (TTM)

DCOY-1073.9%

HCWB-474.1%

Earnings Yield (TTM)

DCOY-1854.7%

HCWB-836.3%

Dividend Yield (TTM)

DCOYN/A

HCWBN/A

Rule of 40

DCOY-3,676.1

HCWB526.4

EV/GP/RG

DCOYN/A

HCWB0.00

Ticker research

View DCOY research View HCWB research

Metric	DCOY Decoy Therapeutics Inc	HCWB HCW Biologics Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$8M
Price	$1.47	$1.60
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	0.38x
EV/Sales	-33.00x	1.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.51x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$7M
Revenue Growth (YoY)	N/A	707.0%
Forward Rev Growth	0.0%	5564.5%
Profitability
Gross Margin (TTM)	48.6%	95.9%
Operating Margin (TTM)	0.0%	23.1%
EBITDA Margin (TTM)	-2668.9%	-82.2%
Net Margin (TTM)	-6348.7%	-318.5%
FCF Margin (TTM)	-3676.1%	-180.6%
Net Income (TTM)	$-14M	$-21M
FCF (TTM)	$-8M	$-12M
EPS (TTM)	-$27.16	-$16.12
ROE (TTM)	-31523.0%	-1932.0%
ROA (TTM)	-16715.0%	-2145.0%
ROIC (TTM)	-31523.0%	-859.0%
Financial Health
Cash	$8M	$741K
Debt	$0	$7M
Net Cash/Debt	$8M	$-6M
Current Ratio (TTM)	1.83x	0.06x
Quick Ratio (TTM)	1.77x	0.05x
Debt/Equity (TTM)	0.00x	0.88x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	2.28
52W Performance	-97.0%	-94.5%
YTD Performance	-81.2%	-76.2%
% from 52W High	-97.4%	-94.3%
% from 52W Low	0.7%	6.7%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.26x
FCF Yield (TTM)	-1073.9%	-474.1%
Earnings Yield (TTM)	-1854.7%	-836.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	526.4
EV/GP/RG	N/A	0.00
Ticker research	View DCOY research	View HCWB research

Valuation

P/S Ratio

HCWB

0.38x

DCOY

3.42x

EV/FCF

HCWB

-0.69x

DCOY

0.90x

Growth & revenue

Revenue Growth TTM

HCWB

707.0%

Forward Revenue Growth

HCWB

5564.5%

DCOY

0.0%

Profitability & performance

Gross Margin

HCWB

95.9%

DCOY

48.6%

ROE

HCWB

-1932.0%

DCOY

-31523.0%

FCF Yield %

HCWB

-474.1%

DCOY

-1073.9%

52-Week Performance

HCWB

-94.5%

DCOY

-97.0%

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

HCWB

HCW Biologics Inc

Market Cap

DCOY$779K

HCWB$3M

Enterprise Value

DCOY$-8M

HCWB$8M

Price

DCOY$1.47

HCWB$1.60

P/E Ratio

DCOYN/A

HCWBN/A

P/S Ratio

DCOY3.42x

HCWB0.38x

EV/Sales

DCOY-33.00x

HCWB1.25x

EV/EBITDA

DCOY0.00x

HCWB0.00x

P/B Ratio

DCOY0.75x

HCWB0.51x

P/FCF Ratio

DCOYN/A

HCWBN/A

EV/FCF

DCOY0.90x

HCWB-0.69x

PEG Ratio

DCOYN/A

HCWBN/A

Forward P/E (NTM)

DCOYN/A

HCWBN/A

Forward P/S (NTM)

DCOYN/A

HCWBN/A

Revenue (TTM)

DCOY$228K

HCWB$7M

Revenue Growth (YoY)

DCOYN/A

HCWB707.0%

Forward Rev Growth

DCOY0.0%

HCWB5564.5%

Gross Margin (TTM)

DCOY48.6%

HCWB95.9%

Operating Margin (TTM)

DCOY0.0%

HCWB23.1%

EBITDA Margin (TTM)

DCOY-2668.9%

HCWB-82.2%

Net Margin (TTM)

DCOY-6348.7%

HCWB-318.5%

FCF Margin (TTM)

DCOY-3676.1%

HCWB-180.6%

Net Income (TTM)

DCOY$-14M

HCWB$-21M

FCF (TTM)

DCOY$-8M

HCWB$-12M

EPS (TTM)

DCOY-$27.16

HCWB-$16.12

ROE (TTM)

DCOY-31523.0%

HCWB-1932.0%

ROA (TTM)

DCOY-16715.0%

HCWB-2145.0%

ROIC (TTM)

DCOY-31523.0%

HCWB-859.0%

Cash

DCOY$8M

HCWB$741K

Debt

DCOY$0

HCWB$7M

Net Cash/Debt

DCOY$8M

HCWB$-6M

Current Ratio (TTM)

DCOY1.83x

HCWB0.06x

Quick Ratio (TTM)

DCOY1.77x

HCWB0.05x

Debt/Equity (TTM)

DCOY0.00x

HCWB0.88x

Debt/Assets (TTM)

DCOY0.0%

HCWB0.0%

Interest Coverage (TTM)

DCOYN/A

HCWBN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

HCWB0.00x

Beta

DCOY0.68

HCWB2.28

52W Performance

DCOY-97.0%

HCWB-94.5%

YTD Performance

DCOY-81.2%

HCWB-76.2%

% from 52W High

DCOY-97.4%

HCWB-94.3%

% from 52W Low

DCOY0.7%

HCWB6.7%

Asset Turnover (TTM)

DCOY0.03x

HCWB0.26x

FCF Yield (TTM)

DCOY-1073.9%

HCWB-474.1%

Earnings Yield (TTM)

DCOY-1854.7%

HCWB-836.3%

Dividend Yield (TTM)

DCOYN/A

HCWBN/A

Rule of 40

DCOY-3,676.1

HCWB526.4

EV/GP/RG

DCOYN/A

HCWB0.00

Ticker research

View DCOY research View HCWB research

Metric	DCOY Decoy Therapeutics Inc	HCWB HCW Biologics Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$8M
Price	$1.47	$1.60
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	0.38x
EV/Sales	-33.00x	1.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.51x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$7M
Revenue Growth (YoY)	N/A	707.0%
Forward Rev Growth	0.0%	5564.5%
Profitability
Gross Margin (TTM)	48.6%	95.9%
Operating Margin (TTM)	0.0%	23.1%
EBITDA Margin (TTM)	-2668.9%	-82.2%
Net Margin (TTM)	-6348.7%	-318.5%
FCF Margin (TTM)	-3676.1%	-180.6%
Net Income (TTM)	$-14M	$-21M
FCF (TTM)	$-8M	$-12M
EPS (TTM)	-$27.16	-$16.12
ROE (TTM)	-31523.0%	-1932.0%
ROA (TTM)	-16715.0%	-2145.0%
ROIC (TTM)	-31523.0%	-859.0%
Financial Health
Cash	$8M	$741K
Debt	$0	$7M
Net Cash/Debt	$8M	$-6M
Current Ratio (TTM)	1.83x	0.06x
Quick Ratio (TTM)	1.77x	0.05x
Debt/Equity (TTM)	0.00x	0.88x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	2.28
52W Performance	-97.0%	-94.5%
YTD Performance	-81.2%	-76.2%
% from 52W High	-97.4%	-94.3%
% from 52W Low	0.7%	6.7%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.26x
FCF Yield (TTM)	-1073.9%	-474.1%
Earnings Yield (TTM)	-1854.7%	-836.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	526.4
EV/GP/RG	N/A	0.00
Ticker research	View DCOY research	View HCWB research